Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, to reduce the risk of kidney failure and ...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...

Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...

Health Canada has now approved Ozempic to reduce the risk of kidney decline among patients with type 2 diabetes.

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.

Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type 2 diabetes patients access to ...

Should Ozempic be added to the water supply? That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the population.

Earlier this month, it said it expects continued competition from copycat versions of its blockbuster obesity drug Wegovy ...

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...